Strides Pharma Science Limited — Important, 24-10-2024: Financial Result Updates

Strides Pharma Science reported unaudited financial results for the quarter and half-year ended September 30, 2024. Total revenue reached ₹12,295.21 million, with a net profit of ₹936.61 million, compared to a loss in the same period last year. The company disclosed an exceptional item loss of ₹38.72 million. Strides announced a merger with Strides Alathur Private Limited and plans for a demerger of certain business segments, pending regulatory approval.